Big Pharma stockholders think so San Diego-based Vical, a firm who is developing an H1N1 vaccine under an agreement with the U.S. Navy saw company shares climb 45 cents, to $2.65 on positive clinical trial news this week. Vical researches and develops biopharmaceutical … [Read more...] about Is There an Upside to the Swine Flu Pandemic?
Archives for July 11, 2009
Epidemiologists Can’t Determine Why Some People are killed by H1N1
Swine Flu's Impact Still A Mystery Around the world, vaccine manufactures are rushing new swine flu (H1N1) vaccines into clinic trials and booking pre-orders from worried Public Health officials, while epidemiologists are still puzzling out how the new flu works and why many … [Read more...] about Epidemiologists Can’t Determine Why Some People are killed by H1N1